Startup Dossier
Bionyra Pharma
Bionyra Pharma is a clinical-stage biotechnology company developing biologic therapies for immune-mediated inflammatory diseases, initially targeting severe atopic dermatitis (eczema) and inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
active
Typestartup
SectorBioTech
LocationParis
About
Bionyra Pharma is a clinical-stage biotechnology company developing biologic therapies for immune-mediated inflammatory diseases, initially targeting severe atopic dermatitis (eczema) and inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.
Structural DNA
Legal Name
Bionyra Pharma
SIREN
990995334
Founders & Team
Funding Lineage
Series A
7 investors
€140.0M
Jun 2026